EID Parry (India) Ltd. - Research Center
500125 EIDPARRY Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 2,894.92 | 2,496.30 | 2,024.25 | 1,874.88 | 1,855.03 |
| Operating profit | 268.47 | 215.90 | 170.53 | 94.49 | -21.12 |
| Interest | 36.03 | 46.09 | 92.72 | 135.66 | 113.43 |
| Gross profit | 490.47 | 445.73 | 463.21 | 99.52 | 56.86 |
| EPS (Rs) | 11.09 | 15.98 | 48.83 | 0.10 | 9.22 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 258.03 | 275.92 | 385.40 | 140.69 | 191.41 |
| Stock adjustment | 34.04 | -28.53 | -6.53 | 12.08 | 128.79 |
| Raw material | 1,831.00 | 1,736.82 | 1,370.63 | 1,260.46 | 1,240.03 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 157.93 | 134.82 | 137.50 | 159.61 | 145.44 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 603.48 | 437.29 | 352.12 | 348.24 | 361.89 |
| Provisions made | - | - | - | - | - |
| Depreciation | 135.05 | 120.11 | 119.99 | 119.56 | 113.77 |
| Taxation | 47.69 | 28.39 | 193.53 | -21.87 | -49.07 |
| Net profit / loss | 196.82 | 283.50 | 864.86 | 1.83 | 163.13 |
| Extra ordinary item | -110.91 | -13.73 | 715.17 | - | 170.97 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 17.75 | 17.74 | 17.71 | 17.70 | 17.70 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 9.27 | 8.65 | 8.42 | 5.04 | -1.14 |
| GPM (%) | 15.56 | 16.08 | 19.22 | 4.94 | 2.78 |
| NPM (%) | 6.24 | 10.23 | 35.89 | 0.09 | 7.97 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis